🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will investigate whether GC1008, an antibody which neutralizes T...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00464321
This study is designed to investigate whether GC1008, an antibody that neut...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00125385
The SABR-ATAC trial (Stereotactic Ablative Radiotherapy and anti-TGFB Antib...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2016-08
Trial ID
NCT02581787
Treatments Being Tested
The purpose of this study is to determine if fresolimumab is safe in treati...
Status
Completed
Location
Boston University School of Medicine; Rheumatology/Arthritis Center
Start Date
2011-01
Trial ID
NCT01284322
Treatments Being Tested
This study is being conducted to evaluate the overall safety and effectiven...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2010-04
Trial ID
NCT01112293
Treatments Being Tested
TGF-β is a cytokine that is found to be upregulated in the bone marrow of p...
Status
Terminated
Location
Icahn School of Medicine at Mount Sinai
Start Date
2011-02
Trial ID
NCT01291784
Treatments Being Tested
Osteogenesis Imperfecta (OI) is a rare disorder that causes bones to break ...
Status
Completed
Location
Oregon Health Science University
Start Date
2017-11-15
Trial ID
NCT03064074
Treatments Being Tested
The primary objectives of this trial are as follows: * to compare the achi...
Status
Completed
Location
Investigational Site Number 4008
Start Date
2012-08
Trial ID
NCT01665391
Treatments Being Tested
Background: * GC1008 is a genetically engineered antibody designed to bloc...
Status
Completed
Location
Cancer Institute of New Jersey
Start Date
2006-07-09
Trial ID
NCT00923169
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, pharmac...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
2006-09
Trial ID
NCT00356460
Treatments Being Tested